Thrivent Financial For Lutherans Axcella Health Inc. Transaction History

Thrivent Financial For Lutherans

  • $52.6 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 17, 2023
BUY
$0.31 - $0.77 $2,635 - $6,545
8,500 Added 23.94%
44,000 $22,000
Q4 2022

Feb 08, 2023
BUY
$0.16 - $1.1 $160 - $1,100
1,000 Added 2.9%
35,500 $12,000
Q3 2022

Nov 14, 2022
BUY
$1.62 - $2.73 $55,890 - $94,185
34,500 New
34,500 $67,000

Others Institutions Holding AXLA

# of Institutions
2
Shares Held
61.6K
Call Options Held
0
Put Options Held
0
View Full List

About Axcella Health Inc.

AXLA Quotes by TradingView
  • Ticker AXLA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 73,500,896
  • Description
  • Axcella Health Inc. operates as a clinical stage biotechnology company in the United States. The company treats complex diseases and enhances health using endogenous metabolic modulator compositions. Its lead product candidates include AXA1665, which is in Phase 2 clinical trial for the reduction in risk of overt hepatic encephalopathy recurrenc...
More about AXLA
Track This Portfolio

Track Thrivent Financial For Lutherans Portfolio

Follow Thrivent Financial For Lutherans and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Thrivent Financial For Lutherans, based on Form 13F filings with the SEC.

News

Stay updated on Thrivent Financial For Lutherans with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email